Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 71,721 | 67,795 | 83,107 | 75,199 | 77,345 |
| Cost of Goods | 54,368 | 50,948 | 60,096 | 50,837 | 58,904 |
| Gross Profit | 17,353 | 16,847 | 23,011 | 24,362 | 18,441 |
| Operating Expenses | 18,190 | 25,018 | 70,372 | 23,457 | 18,154 |
| Operating Income | -469 | -7,217 | -47,265 | 1,742 | 1,191 |
| Interest Expense | 101 | 131 | 120 | 188 | 132 |
| Other Income | 3 | 1,094 | -564 | -1,686 | 516 |
| Pre-tax Income | -567 | -6,254 | -47,949 | -132 | 1,575 |
| Income Tax | -52 | -1,266 | -30,012 | 1,663 | 1,831 |
| Net Income Continuous | -515 | -4,988 | -17,937 | -1,795 | -256 |
| Net Income | $-515 | $-4,988 | $-17,937 | $-1,795 | $-256 |
| EPS Basic Total Ops | -0.02 | -0.15 | -0.55 | -0.05 | -0.01 |
| EPS Basic Continuous Ops | -0.02 | -0.15 | -0.55 | -0.05 | -0.01 |
| EPS Diluted Total Ops | -0.02 | -0.15 | -0.55 | -0.05 | -0.01 |
| EPS Diluted Continuous Ops | -0.02 | -0.15 | -0.55 | -0.05 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -9,999.00 | -9,999.00 | -9,999.00 | -9,999.00 | -9,999.00 |
| EBITDA(a) | $2,243 | $-5,520 | $-42,380 | $4,411 | $4,229 |